REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/23/2025
Back to search
Official data from USPTO
DRUGOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DRUGOME
ST13
US500000088397912Class
9, 35, 36, 42
Filing
88397912
Registration
6083085
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/24/2025
Trademark type
Word
Nice classes
9, 35, 36, 42
Filing date
04/23/2019
Registration date
06/23/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2020
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
OSAKA, JP
Examiner
SMITH, BRIDGETT
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SUMITOMO PHARMA CO. LTD.
SUMITOVANT BIOPHARMA, INC.
Roivant Sciences GmbH
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Technical classification
Nice Classes
Class 9Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for providinganalyzing and generating reports; downloadable computer software for data processing; downloadable computer software for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and information; downloadable computer software for the conversionanalysisprocessingstorage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentfor clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedical researchfor clinical trial and post-market trial data; downloadable computer search engine software for compilingaccessing and providing updated scientificmedicalpharmaceutical and clinical informationnews information of general interest
Class 35
Advertising; business management; business administration; office functions; business research services in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trialspost-market data; business information services; market research; provision of market research information; data processing services; analysis of business data; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market data; systematization and compilation of data in computer databasesin particular compilation of information into computer databases for research and analysis purposes in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcarepharmaceuticalsbiomedicineclinical trialsepidemiological researchpharmacoepidemiological researchpost-market trials and research evaluating epidemiological outcomes
Class 36
Financial analysis; financial consulting; financial valuations and forecasting; financial analysiscompiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and developmentclinical and post-market trials; financial evaluationtrackinganalysisforecastingconsultancyadvisory and research services relating to healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical and post-market trials
Class 42
Scientific and technological servicesscientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computers; pharmaceuticalbiomedicalbiological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trials and post-market trials; cloud computing featuring software for conducing scientific research and analysis in the fields of public healthhealthcarepharmaceutical and biomedical researchclinical trial data and data from examinations carried out after the introduction of medicines on the market; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedicinepharmaceutical and biopharmaceutical research and developmentmedical informationclinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews information of general interest; Artificial intelligence and machine learning statistical analysisconsultancy and reporting for pharmaceutical and biomedical research; information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services
Publications
History of USPTO decisions and trademark events.
30 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/24/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2020
PUBO
PUBLISHED FOR OPPOSITION
04/07/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/25/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/25/2020
ALIE
ASSIGNED TO LIE
02/25/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/25/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/25/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/25/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/10/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
DOCK
ASSIGNED TO EXAMINER
06/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2019
NWAP
NEW APPLICATION ENTERED
04/26/2019
Continuous trademark protection
Get notified about every new filing that threatens DRUGOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.